TABLE 1.
Patient | Age, y | Sex | Tumor Size, cm | Histology | Fuhrman Nuclear Grade | Other Pathology Findings | AJCC Tumor Classification | Anatomic stage |
---|---|---|---|---|---|---|---|---|
1 | 66 | Man | 2.5 | Chromophobe | NA | Extension into perirenal fat | T3a | III |
2 | 60 | Man | 3.5 | Clear cell | 2 | T1a | I | |
3 | 80 | Man | 4.2 | Chromophobe | NA | Tumor necrosis present | T1b | I |
4 | 75 | Woman | 4.5 | Clear cell | 2 | Extension into renal sinus fat | T3a | III |
5 | 75 | Man | 6.5 | Clear cell | 3 | Involving segmental renal vein | T3a | III |
6 | 41 | Man | 5.8 | Clear cell | 4 | Focal rhabdoid feature present; extension into segmental renal vein | T3a | III |
7 | 37 | Woman | 4.9 | Clear cell | 2 | T1b | I | |
8 | 78 | Woman | 7.0 | Clear cell | 3 | Tumor necrosis and rhabdoid features present | T3a | III |
Abbreviations: AJCC, American Joint Committee on Cancer; NA, not applicable (chromophobe renal cell carcinomas are not graded using the Fuhrman nuclear grading system).